To the EditorsIn immunoglobulin light chain (AL) amyloidosis, plasma cell disease burden at diagnosis is a key prognostic factor [1]. When patients have >10% clonal bone marrow plasma cells (BMPCs)...
No takes yet. Share an insight, caveat, or question.
Sarubbi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: